AI assistant
Jazz Pharmaceuticals plc — Director's Dealing 2015
Nov 24, 2015
30751_dirs_2015-11-24_4565f0a0-0547-4a2a-9b9d-127353c13155.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-11-20
Reporting Person: Mulligan Seamus (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-20 | Ordinary Shares | S | 12325.0 | $144.1241 | Disposed | 1146190 | Direct |
| 2015-11-20 | Ordinary Shares | S | 2700.0 | $145.283 | Disposed | 1143490 | Direct |
| 2015-11-20 | Ordinary Shares | S | 1700.0 | $146.25 | Disposed | 1141790 | Direct |
| 2015-11-20 | Ordinary Shares | S | 1000.0 | $147.149 | Disposed | 1140790 | Direct |
| 2015-11-23 | Ordinary Shares | S | 500.0 | $145.126 | Disposed | 1140290 | Direct |
| 2015-11-23 | Ordinary Shares | S | 550.0 | $145.997 | Disposed | 1139740 | Direct |
| 2015-11-23 | Ordinary Shares | S | 2000.0 | $147.4964 | Disposed | 1137740 | Direct |
| 2015-11-23 | Ordinary Shares | S | 5628.0 | $148.0965 | Disposed | 1132112 | Direct |
| 2015-11-23 | Ordinary Shares | S | 1465.0 | $149.2062 | Disposed | 1130647 | Direct |
| 2015-11-23 | Ordinary Shares | S | 100.0 | $150.0 | Disposed | 1130547 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $143.69 to $144.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.73 to $145.71. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.75 to $146.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $146.79 to $147.58. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.75 to $145.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.80 to $146.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $146.81 to $147.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F9: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.82 to $148.7325. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F10: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.91 to $149.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.